These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 1233206)

  • 41. The effect of antacid and aspirin on the bioavailability of isofezolac in man.
    Rocher I; Henry JF; Flouvat B
    Int J Clin Pharmacol Ther Toxicol; 1984 Sep; 22(9):464-9. PubMed ID: 6500763
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Bioavailability of indomethacin capsules in humans (II): correlation with dissolution rate.
    Aoyagi N; Ogata H; Kaniwa N; Ejima A
    Int J Clin Pharmacol Ther Toxicol; 1985 Oct; 23(10):529-34. PubMed ID: 4066077
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lowering of plasma concentrations of (+)-6-methoxy-alpha-methyl-2-naphthaleneacetic acid (naproxen) by aspirin in rats.
    Chaplin MD
    Biochem Pharmacol; 1973 Jul; 22(13):1589-98. PubMed ID: 4729806
    [No Abstract]   [Full Text] [Related]  

  • 44. Disintegration, dissolution, oral absorption in humans of five commercial buffered aspirin dosage forms.
    Chiou WL; Onyemelukwe I
    J Clin Pharmacol; 1974; 14(11-12):597-603. PubMed ID: 4436446
    [No Abstract]   [Full Text] [Related]  

  • 45. The effect of acetylsalicylic acid, phenylbutazone and indomethacin on the binding of 11-hydroxysteroids to plasma proteins in patients with rheumatoid arthritis.
    Stenlake JB; Davidson AG; Jasani MK; Williams WD
    J Pharm Pharmacol; 1968 Dec; 20():Suppl:248S+. PubMed ID: 4388166
    [No Abstract]   [Full Text] [Related]  

  • 46. Effects of aspirin, indomethacin, and sodium salicylate on human erythrocyte membranes as detected with electron spin resonance spectroscopy.
    Mazorow DL; Haug A; Bull R; McGroarty EJ
    Thromb Res; 1985 Dec; 40(6):779-92. PubMed ID: 3003962
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Application of a radiotelemetric system to evaluate the performance of enteric coated and plain aspirin tablets.
    Lui CY; Oberle R; Fleisher D; Amidon GL
    J Pharm Sci; 1986 May; 75(5):469-74. PubMed ID: 3735085
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effect of indomethacin, aspirin, and ibuprofen on bone ingrowth into a porous-coated implant.
    Trancik T; Mills W; Vinson N
    Clin Orthop Relat Res; 1989 Dec; (249):113-21. PubMed ID: 2582661
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Influence of particle size on rectal absorption of aspirin.
    Parrott EL
    J Pharm Sci; 1975 May; 64(5):875-80. PubMed ID: 1151665
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Feasibility of biowaiver extension to biopharmaceutics classification system class III drug products: cimetidine.
    Jantratid E; Prakongpan S; Amidon GL; Dressman JB
    Clin Pharmacokinet; 2006; 45(4):385-99. PubMed ID: 16584285
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Enteric-coated pelletized aspirin. Gastrointestinal blood loss and bioavailability.
    Portek I; Graham G; Fleming A
    Med J Aust; 1981 Jul; 2(1):39-40. PubMed ID: 6974303
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Biopharmaceutical assessment of phenylbutazone and indomethacin preparations.
    Turakka H; Airaksinen MM
    Ann Clin Res; 1974; 6(0):suppl 11:34-43. PubMed ID: 4855463
    [No Abstract]   [Full Text] [Related]  

  • 53. Differential effects of oral administrations to human volunteers of acetylsalicylic acid, sodium salicylate and indomethacin on 12-hydroxyeicosatetraenoic acid formation by stimulated platelets.
    Maderna P; Caruso D; Tremoli E; Galli G
    Thromb Res; 1988 Nov; 52(3):197-206. PubMed ID: 3194896
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A novel relationship between plasma kininogen and rheumatoid.
    Sharma JN; Zeitlin IJ; Brooks PM; Dick WC
    Agents Actions; 1976 Feb; 6(1-3):148-53. PubMed ID: 941790
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gestational age and indomethacin elimination in the neonate.
    Evans MA; Bhat R; Vidyasagar D; Vadapalli M; Fisher E; Hastreiter A
    Clin Pharmacol Ther; 1979 Dec; 26(6):746-51. PubMed ID: 498716
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of type and concentration of vehicles on the dissolution rate of a poorly soluble drug (indomethacin) from liquisolid compacts.
    Nokhodchi A; Javadzadeh Y; Siahi-Shadbad MR; Barzegar-Jalali M
    J Pharm Pharm Sci; 2005 Jan; 8(1):18-25. PubMed ID: 15946594
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of drugs on urate binding to plasma proteins.
    Bluestone R; Kippen I; Klinenberg JR
    Br Med J; 1969 Dec; 4(5683):590-3. PubMed ID: 5356547
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Failure of commercial buffered aspirin tablets to pass official disintegration test.
    Chiou WL
    Am J Hosp Pharm; 1973 Mar; 30(3):199. PubMed ID: 4690476
    [No Abstract]   [Full Text] [Related]  

  • 59. In vitro and in vivo evaluation of single-unit commercial immediate-and sustained-release capsules compared with multiple-unit polystyrene microparticles dosage forms of indomethacin.
    Tamilvanan S; Sa B
    PDA J Pharm Sci Technol; 2008; 62(3):177-90. PubMed ID: 18661867
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interaction of omeprazole with enteric-coated salicylate tablets.
    Nefesoglu FZ; Ayanoglu-Dülger G; Ulusoy NB; Imeryüz N
    Int J Clin Pharmacol Ther; 1998 Oct; 36(10):549-53. PubMed ID: 9799060
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.